Health Effects of the Standardized Research E-Cigarette for Harm Reduction in Smokers With HIV

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Cigarette smoking is more prevalent (50-70%) in persons living with HIV in the U.S. when compared with the general population and is linked to increased rates of heart disease, lung diseases and infections, and lung cancers. Because of their high levels of nicotine dependence, low quit rates, and familiarity with harm reduction, HIV-positive smokers may view the use of alternative nicotine delivery products, such as electronic cigarettes (ECs), as an attractive option for reducing and eventually stopping combustible cigarette use. However, little is known about the health effects of electronic cigarette use in HIV-positive smokers. Some studies have shown that electronic cigarette use was associated with increased confidence to quit smoking in the general population. The primary objectives of this project are to examine whether HIV-positive smokers, who are unwilling or unable to quit smoking, will substitute an electronic cigarette for regular cigarettes, and to examine whether there are any changes in heart and lung health in HIV-positive smokers who switch from regular cigarettes to electronic cigarettes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• diagnosed with and engaged in care for HIV (defined as at least one HIV clinic medical appointment within the past six month period)

• at least 18 years of age

• smoke at least 5 cigarettes per day for longer than one year

• exhaled carbon monoxide (CO) level greater than 5 at BL

Locations
United States
Rhode Island
Brown University School of Public Health
RECRUITING
Providence
Contact Information
Primary
PATRICIA A CIOE, PhD
patricia_cioe@brown.edu
401-863-6638
Backup
Jasmine DiLorenzo, BA
jasminette_dilorenzo@brown.edu
401-863-6645
Time Frame
Start Date: 2022-03-01
Estimated Completion Date: 2024-12-30
Participants
Target number of participants: 72
Treatments
Experimental: Active condition
Participants in the active condition will be provided with the Standardized Research Electronic Cigarette (SREC) and will be encouraged to use the SREC whenever they would normally smoke a cigarette.
No_intervention: Standard Condition
Participants in this condition will be asked to continue to smoke their usual brand of cigarettes.
Related Therapeutic Areas
Sponsors
Leads: Brown University

This content was sourced from clinicaltrials.gov